Perform Another (Advanced) Search

1.  Study Posting (4519) Trial #97980, Anemia, Santander, Spain
...4519) Trial #97980, Anemia, Santander, Spain Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

2.  Study Posting (4519) Trial #97966, Anemia, Malaga, Spain
...4519) Trial #97966, Anemia, Malaga, Spain Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

3.  Study Posting (4519) Trial #96954, Anemia, Madrid, Spain
...4519) Trial #96954, Anemia, Madrid, Spain Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

4.  Study Posting (4519) Trial #96861, Anemia, Barcelona, Spain
...4519) Trial #96861, Anemia, Barcelona, Spain Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

5.  Study Posting (4519) Trial #100740, Anemia, Vicenza, Italy
...4519) Trial #100740, Anemia, Vicenza, Italy Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

6.  Study Posting (4519) Trial #99825, Anemia, Pavia, Italy
...4519) Trial #99825, Anemia, Pavia, Italy Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

7.  Study Posting (4519) Trial #97723, Anemia, Modena, Italy
...4519) Trial #97723, Anemia, Modena, Italy Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

8.  Study Posting (4519) Trial #103939, Anemia, Milano, Italy
...4519) Trial #103939, Anemia, Milano, Italy Trial Information A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. Status: Completed Protocol Number: BA16286 Sponsor: Hoffmann-La Roche Company ...
...Title: A randomized, open-label study of dose conversion factors for maintenance subcutaneous Mircera in dialysis patients with chronic renal anemia Brief Summary: This study will determine the appropriate dose and ...
View Page

9.  Study Posting (4519) Trial #101050, Anemia, Chonburi, Thailand
...Anemia, Chonburi, Thailand Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

10.  Study Posting (4519) Trial #100162, Anemia, Bangkok, Thailand
...Anemia, Bangkok, Thailand Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

11.  Study Posting (4519) Trial #147579, Anemia, Lausanne, Switzerland
...Anemia, Lausanne, Switzerland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

12.  Study Posting (4519) Trial #97992, Anemia, Santander, Spain
...Anemia, Santander, Spain Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

13.  Study Posting (4519) Trial #100451, Anemia, Bilbao, Spain
...Anemia, Bilbao, Spain Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

14.  Study Posting (4519) Trial #100898, Anemia, Wroclaw, Poland
...Anemia, Wroclaw, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

15.  Study Posting (4519) Trial #101018, Anemia, Wolomin, Poland
...Anemia, Wolomin, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

16.  Study Posting (4519) Trial #97864, Anemia, Szczecin, Poland
...Anemia, Szczecin, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

17.  Study Posting (4519) Trial #99089, Anemia, Poznan, Poland
...Anemia, Poznan, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

18.  Study Posting (4519) Trial #97830, Anemia, Lodz, Poland
...Anemia, Lodz, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

19.  Study Posting (4519) Trial #96810, Anemia, Krakow, Poland
...Anemia, Krakow, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page

20.  Study Posting (4519) Trial #101017, Anemia, Gdynia, Poland
...Anemia, Gdynia, Poland Trial Information A Study of Mircera for the Treatment of Anemia in Dialysis Patients Status: Completed Protocol Number: BA16736 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
...randomized, open-label study of the effect of intravenous Mircera on hemoglobin level/correction in dialysis patients with chronic kidney disease Brief Summary: This study will assess the efficacy and safety ...
View Page